CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

TaiGen files US IND for its influenza antiviral TG-1000

TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

Why We Should Be Cautious With COVID-19 Medical Research

Thalidomide’s history is a grim reminder of what can go wrong when a drug comes to market without proper clinical trials and oversight.

COVID-19 Vaccine Talk; Here Is Why We Need to Tap the Brakes

  Covid-19 cases are once again on the rise. Hospitalizations are increasing. The prospect of a brutal third wave seems more likely than ever. We...

Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds.